Identification of a modified coagulation factor X with enhanced activation properties as potential hemostatic agent

In conclusion, these data suggest that the factor X variant described here could potentially serve as a bypassing agent independent of the inhibitor status of hemophilia patients. However, more research is needed to further investigate the potential of this molecule.PMID:33962291 | DOI:10.1016/j.bcmd.2021.102570
Source: Blood Cells, Molecules and Diseases - Category: Hematology Authors: Source Type: research